Advertisement

Topics

Syntellia Company Profile

14:41 EDT 23rd September 2018 | BioPortfolio

Inspired by the application of artificial intelligence in everyday technology, Syntellia was formed by entrepreneurs with a successful track record to bring disruptive innovation to computing and mobile markets. The company’s flagship product Fleksy revolutionizes typing on smartphones through patented predictive text technology. Syntellia’s autocorrect engine and interface are so powerful and intuitive that visually impaired users have been able to type as easily as sighted people through Fleksy on a touchscreen device. For more information please visit www.syntellia.com.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Syntellia

Inspired by the application of artificial intelligence in everyday technology, Syntellia was formed by entrepreneurs with a successful track record to bring disruptive innovation ...

More Information about "Syntellia" on BioPortfolio

We have published hundreds of Syntellia news stories on BioPortfolio along with dozens of Syntellia Clinical Trials and PubMed Articles about Syntellia for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Syntellia Companies in our database. You can also find out about relevant Syntellia Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record